| 1 |
32436323 | Fixed-ratio combination of basal insulin and glucagon-like peptide-1 receptor agonists in the treatment of Japanese people with type 2 diabetes: An innovative solution to a complex therapeutic challenge. | 2020 Sep |
1 |
| 2 |
27043162 | Postprandial plasma glucose effects of once-weekly albiglutide for the treatment of type 2 diabetes. | 2016 May |
1 |
| 3 |
26428031 | Differential effects of prandial and non-prandial GLP-1 receptor agonists in type 2 diabetes therapy. | 2015 |
1 |
| 4 |
24641271 | Pronounced reduction of postprandial glucagon by lixisenatide: a meta-analysis of randomized clinical trials. | 2014 Sep |
1 |
| 5 |
29922357 | Lixisenatide - A New Glucagon-like Peptide 1 Receptor Agonist in the Treatment of Type 2 Diabetes. | 2013 Aug |
1 |
| 6 |
22436069 | Differentiating among incretin therapies: a multiple-target approach to type 2 diabetes. | 2012 Oct |
1 |
| 7 |
21651690 | Glucagon-like peptide-1 receptor agonists versus insulin in inadequately controlled patients with type 2 diabetes mellitus: a meta-analysis of clinical trials. | 2011 Nov |
1 |